Feb 01, 2023
Welcome to the first issue of ASCO Connection in 2023—we are kicking off the new year with a wide-ranging issue.
Jan 31, 2023
Even as I wrote the first paragraph of this article, I had 6 notifications on my iPhone. We all suffer from distraction nowadays!
Jan 19, 2023
Dr. Kathryn DeCarli and Dr. Jonathan Marron consider the actions an oncologist must, ought, and should take when offering professional medical interpretation services to a patient.
Dec 08, 2022
ASCO’s delegation to the American Medical Association’s House of Delegates (AMA HOD) recently traveled to Honolulu for the Interim meeting. Our resolutions primarily focused on the threat of legislation that could criminalize medically necessary care in the wake of the Supreme Court’s decision...
Subscribe to this column
ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.
Nov 10, 2022
ASCO president Dr. Eric P. Winer and Nominating Committee chair Dr. Beverly S. Mitchell call upon all eligible voters to make their voices heard in the ASCO election.
Nov 03, 2021
ASCO president Dr. Everett E. Vokes and Nominating Committee chair Dr. Sharon H. Giordano have a call to action for all voting-eligible members.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.